Get a Quote

Why Protein R&D Is a Different Beast: Why It’s Not Comparable to Capsules, Tablets or Sachets

Protein R&D is often misunderstood — especially by brands that already developed capsules, tablets or sachets and assume protein will be “more of the same, just bigger”.
It is not.
From a manufacturing and development perspective, protein products live in a completely different complexity class. Comparing protein R&D to capsule, tablet or sachet development is like comparing furniture assembly to structural engineering.
Both involve materials.
Only one can collapse under its own weight.

Why Capsules, Tablets and Sachets Are Predictable

Capsule, tablet and sachet development is mostly formulation-driven, not experience-driven.
  • -1-

    You work with:

    defined actives
    defined excipients
    narrow interaction space
    limited sensory exposure
  • -2-

    If the formulation meets:

    dosage accuracy
    stability
    regulatory requirements
  • -3-

    …the product is largely done.

    Taste plays a secondary role or none at all. Mouthfeel is irrelevant. Solubility rarely matters. The consumer experience is short and controlled.
    R&D in these formats is finite.
You iterate until specifications are met — and then you stop.

Protein R&D Never Stops at “Technically Correct”

Protein products are consumed as food.
That single fact changes everything.
Protein R&D must simultaneously solve:
  1. Nutrition
  2. Taste
  3. Aroma
  4. Mouthfeel
  5. Solubility
  6. Foam behavior
  7. Repeat consumption
  8. Long-term sensory fatigue
  9. Manufacturability at scale

And all of these dimensions interact.
You don’t “finish” protein R&D when the formulation works.
You finish it when the product survives real, repeated, daily

One Flavor ≠ One Project

One protein flavor can take 3–6 months of active R&D.
And that’s not an outlier — that’s normal.
Why?
Because every change breaks something else.
You adjust sweetness → bitterness shifts.

You add cocoa → flowability and dusting change.

You change aroma → foam increases.

You add antifoam → mouthfeel becomes thin.

You reduce sugar → texture collapses.
Here is a detail most brands underestimate completely:
This is not poor planning.
Protein does not “carry” flavor.
This is protein behavior.

The Hidden Reality: Ingredient Chaos

Protein R&D is not done with a neat ingredient list.
  • In our office alone, we work with over 50 different types of cocoa:
    Different fat contents, alkalized and non-alkalized, origin-dependent, process-dependent. Each behaves differently in a protein matrix. Each changes bitterness, color, mouthfeel and flow.
    The same applies to excipients and functional agents.
  • Our shelves include materials sourced from:
    Japan, China, India, multiple EU countries — each with different purity, particle behavior, sensory impact and batch variability.
  • On paper, many of these ingredients are “the same”.
    In practice, they absolutely are not.

    Protein R&D means testing combinations that look identical in specification — and behave completely differently in reality.

Logistics Nobody Plans For

  • Every R&D iteration triggers logistics:

    • New supplier MOQs
    • Lead times
    • Documentation
    • Batch inconsistency
    • Re-testing after restock
  • And then — the most painful part — reproducibility.

    A flavor that works today must work again:
    Until that is proven, the product is not real.

The Budget Problem Nobody Likes to Hear

  • Protein R&D does not have a clean, fixed price.

    Even for us, as a CMO with infrastructure, experience and supplier access, protein R&D is something we approach carefully — because the number of iterations cannot be guaranteed in advance.
    That makes protein R&D:
    time-intensive
    ingredient-intensive
    • capital-intensive
  • If a brand does not have:

    budget for months of iteration
    tolerance for failed prototypes
    readiness to order many test ingredients
    patience for “almost works” phases

    …protein R&D becomes a liability.

This Is Why We Treat Protein Differently

At BF-ESSE, we are very open about this:
  • Protein R&D is harder than capsules, tablets or sachets — even for us.

    Not because we lack competence.
    But because protein products operate in a space where chemistry, physics, sensory perception and human behavior collide.
  • That is why we insist on:

    • proven systems first
    • white-label bases for early brands
    • R&D only when the business case is real
  • This is not conservatism.
    It is respect for complexity.

The Honest Conclusion

If you have developed capsules or tablets before,
protein will surprise you.
If you expect protein R&D to be linear,
it will disappoint you.
If you underestimate the sensory and system dimension
it will punish you.

Protein R&D is not impossible.

It is premature complexity.

But it is not a beginner category.
For many brands, starting with protein R&D is not ambition.
And complexity always charges interest.
If you underestimate protein, it will hit you back — hard.
On one single protein flavor, we had three chemists, our COO personally involved, one business development manager and two people in purchasing working in parallel — for almost three months.
Protein does not fail on the first sip. It fails on the fifth, the tenth, the twentieth — when bitterness creeps in, foam suddenly appears, mouthfeel collapses, or flavor fatigue sets in. And if you miss that moment in R&D, the market will catch it for you later.
This is why protein R&D is not comparable to capsules, tablets or sachets. Those formats test technical correctness.

Not on a portfolio
And humans are far less forgiving than specifications.
On one flavor
Protein tests human tolerance.